Know Cancer

or
forgot password

Women At Risk: The High Risk Breast Cancer Program


N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Women At Risk: The High Risk Breast Cancer Program


This is a longitudinal cohort study that collects data of eligible women at risk for
developing breast cancer. Patient information will be entered into a secured computerized
database that is used for research on the prevention, early detection and treatment of
breast cancer.


Inclusion Criteria:



- one or more first-degree relatives (mother, daughter, or sister) with pre-menopausal
breast cancer

- two or more first-degree relatives with post-menopausal breast cancer

- tested positive for a BRCA1 or BRCA2 mutation

- a history of biopsy-proven atypical ductal hyperplasia or atypical lobular
hyperplasia

- a history of biopsy-proven lobular neoplasia (lobular carcinoma in situ)

Exclusion Criteria:

- DCIS (ductal carcinoma in situ)

- previous diagnosis of breast cancer

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Principal Investigator

Kathie-Ann Joseph, MD, MPH

Investigator Role:

Principal Investigator

Investigator Affiliation:

Columbia University/New York Presbyterian Hospital

Authority:

United States: Institutional Review Board

Study ID:

AAAA4649

NCT ID:

NCT01034891

Start Date:

January 1991

Completion Date:

Related Keywords:

  • Breast Cancer
  • BRCA mutation
  • benign breast disease
  • family history of breast cancer
  • strong family history of breast cancer
  • atypical ductal hyperplasia
  • atypical lobular hyperplasia
  • high risk for breast cancer
  • Breast Neoplasms

Name

Location

Women At Risk, Columbia University Medical CenterNew York, New York  10032
Women At Risk, Weill CornellNew York, New York  10065